Clinical Trials Directory

Trials / Completed

CompletedNCT05679609

Incentive Spirometry in Routine Management of COPD Patients

Value of Incentive Spirometry in Routine Management of COPD Patients and Its Effect on Diaphragmatic Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The incentive spirometer is a device that encourages patients, with visual and other positive feedback, to maximally inflate their lungs and sustain that inflation. However, its efficacy in patients with COPD has been little documented especially in diaphragmatic function. This study tried to assess the role of incentive spirometry on Spirometric functions, Sonographic diaphragmatic function, and the scale of dyspnea in COPD patients with exacerbation and with follow-up of these parameters after 2 months.

Detailed description

Forty COPD patients were admitted with an acute exacerbation and the patients were divided randomly into 2 equal groups: the first used the incentive spirometer together with medical treatment (according to GOLD guidelines) for 2 months and the second received only medical treatment for 2 months. All participants, on admission, underwent assessment of mMRC dyspnea scale, spirometry, arterial blood gases, and diaphragmatic ultrasound. Then, a follow-up of the participants was done after 2 months with the same parameters and a comparison between both groups was done.

Conditions

Interventions

TypeNameDescription
DEVICEincentive spirometryIt is flow-oriented that has 3 chambers, (600, 900, and 1200 cc/s) and it has a mouthpiece and a ball in each chamber. After a quiet exhalation, each participant was instructed to take slow full inspirations and to keep as long as he can for at least 5 seconds, then he slowly expires. The device is used every hour at least 5 to 10 times in the session during wake time.

Timeline

Start date
2021-03-01
Primary completion
2022-05-01
Completion
2022-07-01
First posted
2023-01-11
Last updated
2023-01-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05679609. Inclusion in this directory is not an endorsement.